CN110122862A - 一种降低血糖的特殊医学用途食品及其制备方法 - Google Patents
一种降低血糖的特殊医学用途食品及其制备方法 Download PDFInfo
- Publication number
- CN110122862A CN110122862A CN201910465903.XA CN201910465903A CN110122862A CN 110122862 A CN110122862 A CN 110122862A CN 201910465903 A CN201910465903 A CN 201910465903A CN 110122862 A CN110122862 A CN 110122862A
- Authority
- CN
- China
- Prior art keywords
- weight
- vitamin
- special medicine
- medicine purposes
- minerals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 53
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 239000008280 blood Substances 0.000 title claims abstract description 25
- 210000004369 blood Anatomy 0.000 title claims abstract description 25
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 23
- 239000008103 glucose Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims description 15
- 239000011782 vitamin Substances 0.000 claims abstract description 54
- 229940088594 vitamin Drugs 0.000 claims abstract description 46
- 229930003231 vitamin Natural products 0.000 claims abstract description 46
- 235000013343 vitamin Nutrition 0.000 claims abstract description 46
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 41
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 34
- 239000011707 mineral Substances 0.000 claims abstract description 34
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 16
- 150000001413 amino acids Chemical class 0.000 claims abstract description 15
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 13
- 239000002773 nucleotide Substances 0.000 claims abstract description 8
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 8
- 235000010755 mineral Nutrition 0.000 claims description 33
- 239000002243 precursor Substances 0.000 claims description 25
- 235000019197 fats Nutrition 0.000 claims description 15
- 235000018102 proteins Nutrition 0.000 claims description 15
- 235000001014 amino acid Nutrition 0.000 claims description 14
- 229940024606 amino acid Drugs 0.000 claims description 14
- PFRQBZFETXBLTP-RCIYGOBDSA-N 2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-3-methyl-1,4-dihydronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-RCIYGOBDSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- 235000014633 carbohydrates Nutrition 0.000 claims description 12
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 102000040350 B family Human genes 0.000 claims description 9
- 108091072128 B family Proteins 0.000 claims description 9
- 239000000654 additive Substances 0.000 claims description 9
- 230000000996 additive effect Effects 0.000 claims description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 8
- CAXNYFPECZCGFK-UHFFFAOYSA-N 2-phenyl-2-pyridin-2-ylacetonitrile Chemical compound C=1C=CC=NC=1C(C#N)C1=CC=CC=C1 CAXNYFPECZCGFK-UHFFFAOYSA-N 0.000 claims description 8
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 8
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 8
- 229930003471 Vitamin B2 Natural products 0.000 claims description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 8
- 235000013312 flour Nutrition 0.000 claims description 8
- 229960002477 riboflavin Drugs 0.000 claims description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 8
- 235000019155 vitamin A Nutrition 0.000 claims description 8
- 239000011719 vitamin A Substances 0.000 claims description 8
- 235000019164 vitamin B2 Nutrition 0.000 claims description 8
- 239000011716 vitamin B2 Substances 0.000 claims description 8
- 229940045997 vitamin a Drugs 0.000 claims description 8
- 102000004407 Lactalbumin Human genes 0.000 claims description 7
- 108090000942 Lactalbumin Proteins 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 6
- 240000002853 Nelumbo nucifera Species 0.000 claims description 6
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 6
- 229930003451 Vitamin B1 Natural products 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 6
- 229960000367 inositol Drugs 0.000 claims description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 6
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 6
- 229960003495 thiamine Drugs 0.000 claims description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 6
- 235000010374 vitamin B1 Nutrition 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 235000000638 D-biotin Nutrition 0.000 claims description 5
- 239000011665 D-biotin Substances 0.000 claims description 5
- 240000007049 Juglans regia Species 0.000 claims description 5
- 235000009496 Juglans regia Nutrition 0.000 claims description 5
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 5
- 108010073771 Soybean Proteins Proteins 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- 102000007544 Whey Proteins Human genes 0.000 claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 125000005456 glyceride group Chemical group 0.000 claims description 5
- 239000011700 menaquinone-7 Substances 0.000 claims description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 5
- 235000019175 phylloquinone Nutrition 0.000 claims description 5
- 239000011772 phylloquinone Substances 0.000 claims description 5
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 5
- 229960001898 phytomenadione Drugs 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 235000020234 walnut Nutrition 0.000 claims description 5
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 4
- 229930003270 Vitamin B Natural products 0.000 claims description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- 235000021466 carotenoid Nutrition 0.000 claims description 4
- 150000001747 carotenoids Chemical class 0.000 claims description 4
- 229960001231 choline Drugs 0.000 claims description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- 229960003080 taurine Drugs 0.000 claims description 4
- 235000019156 vitamin B Nutrition 0.000 claims description 4
- 239000011720 vitamin B Substances 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- 229920002488 Hemicellulose Polymers 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 3
- 229930064664 L-arginine Natural products 0.000 claims description 3
- 235000014852 L-arginine Nutrition 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 3
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 3
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 239000005862 Whey Substances 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- PVBRXXAAPNGWGE-LGVAUZIVSA-L disodium 5'-guanylate Chemical compound [Na+].[Na+].C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O PVBRXXAAPNGWGE-LGVAUZIVSA-L 0.000 claims description 3
- 229960002061 ergocalciferol Drugs 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- -1 iron ion Chemical class 0.000 claims description 3
- 229920005610 lignin Polymers 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 235000014571 nuts Nutrition 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 229940001941 soy protein Drugs 0.000 claims description 3
- 235000019158 vitamin B6 Nutrition 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 235000001892 vitamin D2 Nutrition 0.000 claims description 3
- 239000011653 vitamin D2 Substances 0.000 claims description 3
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 3
- 235000005282 vitamin D3 Nutrition 0.000 claims description 3
- 239000011647 vitamin D3 Substances 0.000 claims description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- 229940021056 vitamin d3 Drugs 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 2
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 2
- 239000006189 buccal tablet Substances 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 229940068682 chewable tablet Drugs 0.000 claims description 2
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 229920000591 gum Polymers 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 2
- 229940006461 iodide ion Drugs 0.000 claims description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 2
- 229910001437 manganese ion Inorganic materials 0.000 claims description 2
- 229920001206 natural gum Polymers 0.000 claims description 2
- 229910001414 potassium ion Inorganic materials 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 229910001415 sodium ion Inorganic materials 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 241000218636 Thuja Species 0.000 claims 1
- 229910001431 copper ion Inorganic materials 0.000 claims 1
- KURVIXMFFSNONZ-WFIJOQBCSA-L disodium;[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(=O)NC(=O)C=C1 KURVIXMFFSNONZ-WFIJOQBCSA-L 0.000 claims 1
- 238000000855 fermentation Methods 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 229940061671 uridine 5-mo-phos disod Drugs 0.000 claims 1
- 230000000291 postprandial effect Effects 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 239000011812 mixed powder Substances 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 229910001220 stainless steel Inorganic materials 0.000 description 7
- 239000010935 stainless steel Substances 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 239000003538 oral antidiabetic agent Substances 0.000 description 3
- 229940127209 oral hypoglycaemic agent Drugs 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 229930010555 Inosine Natural products 0.000 description 2
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 2
- FOGRQMPFHUHIGU-UHFFFAOYSA-N Uridylic acid Natural products OC1C(OP(O)(O)=O)C(CO)OC1N1C(=O)NC(=O)C=C1 FOGRQMPFHUHIGU-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 229960003786 inosine Drugs 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229940125395 oral insulin Drugs 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 description 2
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000002711 medium chain fatty acid esters Chemical class 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003505 terpenes Chemical group 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本申请公开一种特殊医学用途食品，所述特殊医学用途食品包含蛋白质13重量％‑17重量％，维生素0.5重量％‑1.5重量％，矿物质4重量％‑7重量％，碳水化合物30重量％‑40重量％，脂肪8重量％‑1O重量％，膳食纤维30重量％‑43重量％，氨基酸1重量％‑1.5重量％和核苷酸0.01重量％‑0.02重量％。本申请的特殊医学用途食品具有降低血糖的作用。
Description
技术领域
本申请涉及特殊医学食品领域，尤其涉及一种降低血糖的特殊医学用途食品及其制备方法。
背景技术
糖尿病是一组以高血糖为特征的代谢性疾病。高血糖则是由于胰岛素分泌缺陷或其生物作用受损，或两者兼有而引起。糖尿病时长期存在的高血糖，导致各种组织，特别是眼、肾、心脏、血管、神经的慢性损害、功能障碍。引起糖尿病的病因复杂，目前比较认可的因素有遗传原因、病毒感染原因、自身免疫原因，其他疾病的继发原因等，但是最大原因还是饮食的问题。随着人民生活条件越来越好，精致饮食，高糖饮食，高蛋白高脂饮食，饮食不规律，饮酒，吸烟等不良习惯，加上缺乏足够运动来消耗所摄入能量，能量过剩而引起糖尿病。目前治疗糖尿病的主要是口服降糖药或者注射胰岛素，口服降糖药或者注射胰岛素虽然能控制血糖，但两者都有导致低血糖风险。所以在糖尿病早期如果通过合理的饮食控制跟运动能达到一定程度上控制血糖。如果患者在饮食上没有进行科学的控制，即使口服降糖药或者注射胰岛素对控制血糖的稳定也是有很大影响，血糖的波动对患者的健康也产生极大的影响，也大大的增加并发症的风险。
发明内容
基于以上的实际存在的问题，本申请提供了一种含有维生素K2，具有降低血糖的特医食品及制备方法。该特医食品优点是为高血糖患者提供满足身体代谢所需的优质蛋白质，多种维生素，矿物质，氨基酸，膳食纤维，脂肪，碳水化合物。该配方食品可以满足高血糖患者每天的营养需求，其中的分离大豆蛋白粉、浓缩大豆蛋白粉是植物蛋白，蛋白质含量较高，还含有其他的人体必须氨基酸，胆固醇更低；乳清蛋白有助于降低超重者的体重和餐后糖负荷，降低肥胖相关疾病发生的风险；高膳食纤维能增加饱腹感，低饱和脂肪，短链脂肪酸，有益于肠道有益菌的生长；低血糖生成指数碳水化合物的摄入，能减少其他不必要的能量摄入。其中维生素C可以清除活性氧(ROS)和活性氮(RNS)，保护脂质过氧化，改善空腹血糖，糖化血红蛋白，总胆固醇和三酰甘油水平；维生素E能能减轻血糖过高引起的血管损伤，预防并延缓并发症尤其是心血管并发症的发生；锌可以影响胰岛素的合成，贮存，分泌以及结构的完整性，调节胰岛素和受体水平，在物质代谢中起胰岛素样作用肉碱，牛磺酸和肌醇也有助于减轻高血糖糖尿病症状，减少并发症；尤其是其中所含的维生素K2能够增强胰岛素敏感性，改善胰岛素抵抗从而能有效降低血糖，血糖的有效控制也就能够最大限度的减少并发症的产生。
具体地，本申请提供了一种特殊医学用途食品，其中，所述特殊医学用途食品包含蛋白质13重量％-17重量％，维生素0.5重量％-1.5重量％，矿物质4重量％-7重量％，碳水化合物30重量％-40重量％，脂肪8重量％-10重量％，膳食纤维30重量％-43重量％，氨基酸1重量％-1.5重量％和核苷酸0.01重量％-0.02重量％。
在本申请中，所述特殊医学用途食品还可以包含特殊医学用途食品可接受的添加剂；
所述特殊医学用途食品可接受的添加剂可以选自润滑剂和润湿剂中的一种或两种。
在本申请中，所述特殊医学用途食品可以为口服制剂，优选地片剂或颗粒剂。
在本申请中，所述特殊医学用途食品可以为分散片、含化片或口嚼片。
在本申请中，所述蛋白质可以选自大豆蛋白粉、核桃粉、小麦粉和乳清蛋白中的任一种或更多种；
所述大豆蛋白可以为分离大豆蛋白粉或浓缩大豆蛋白粉；
所述乳清蛋白可以为分离乳清蛋白或浓缩乳清蛋白。
在本申请中，所述维生素可以选自维生素A、B族维生素、D族维生素、氧化胆碱、维生素E、维生素C、D-生物素、烟酸、肌醇、D-泛酸钙、叶酸、维生素K2和维生素K1中的任一种或更多种；
所述维生素A可以为类胡萝卜素前体物质；
所述B族维生素可以选自维生素B1、维生素B2、维生素B6、维生素12、维生素B1前体、维生素B2前体、维生素B前体6和维生素12前体中的任一种或更多种；
所述D族维生素可以选自D2、维生素D3、维生素D2前体和维生素D3前体中的任一种或更多种，优选维生素D3；
所述维生素K2可以选自化学合成或天然发酵的MK1至MK14中的任一种或更多种，优选天然发酵的MK-7。
维生素K2，也称甲基萘醌(Menaquinone)，通常用MK来表示。它由一组化合物组成，共有14种形式，差别在于侧链的长短不一。MK是一系列含有2-甲基-1，4-萘醌母核及C3位带有数目不等的异戊二烯结构单元的萜烯侧链化合物的统称，根据萜烯侧链上碳元素的数目，可分为K2(10)、K2(20)、K2(35)、K2(40)等，K2(35)就是代表MK-7。
在本申请的一些实施方案中，所述特殊医学用途食品可以包含蛋白质13重量％-17重量％，维生素0.5重量％-1.5重量％，矿物质4重量％-7重量％，碳水化合物30重量％-40重量％，脂肪8重量％-10重量％，膳食纤维30重量％-43重量％，氨基酸1重量％-1.5重量％和核苷酸0.01重量％-0.02重量％。所述特殊医学用途食品还可以包含特殊医学用途食品可接受的添加剂；所述特殊医学用途食品可接受的添加剂可以选自润滑剂和润湿剂中的一种或两种。所述蛋白质可以选自大豆蛋白粉、核桃粉、小麦粉和乳清蛋白中的任一种或更多种。所述维生素可以选自维生素A、B族维生素、D族维生素、氧化胆碱、维生素E、维生素C、D-生物素、烟酸、肌醇、D-泛酸钙、叶酸、维生素K2和维生素K1中的任一种或更多种；所述维生素A可以为类胡萝卜素前体物质；所述B族维生素可以选自维生素B1、维生素B2、维生素B6、维生素12、维生素B1前体、维生素B2前体、维生素B前体6和维生素12前体中的任一种或更多种；所述D族维生素可以选自D2、维生素D3、维生素D2前体和维生素D3前体中的任一种或更多种，优选维生素D3；所述维生素K2可以选自化学合成或天然发酵的MK1至MK14中的任一种或更多种，优选天然发酵的MK-7。
在本申请的一些实施方案中，所述特殊医学用途食品可以包含蛋白质13重量％-17重量％，维生素0.5重量％-1.5重量％，矿物质4重量％-7重量％，碳水化合物30重量％-40重量％，脂肪8重量％-10重量％，膳食纤维30重量％-43重量％，氨基酸1重量％-1.5重量％和核苷酸0.01重量％-0.02重量％。所述特殊医学用途食品还可以包含特殊医学用途食品可接受的添加剂；所述特殊医学用途食品可接受的添加剂可以选自润滑剂和润湿剂中的一种或两种。所述蛋白质可以选自大豆蛋白粉、核桃粉、小麦粉和乳清蛋白中的任一种或更多种。所述维生素可以选自维生素A、B族维生素、D族维生素、氧化胆碱、维生素E、维生素C、D-生物素、烟酸、肌醇、D-泛酸钙、叶酸、维生素K2和维生素K1中的任一种或更多种；所述维生素A可以为类胡萝卜素前体物质；所述B族维生素可以选自维生素B1、维生素B2、维生素B6、维生素12、维生素B1前体、维生素B2前体、维生素B前体6和维生素12前体中的任一种或更多种；所述D族维生素优选地为维生素D3；所述维生素K2优选地为天然发酵的MK-7。
在本申请中，所述矿物质可以选自含钠离子的矿物质、含钾离子的矿物质、含铜离子的矿物质、含镁离子的矿物质、含铁离子的矿物质、含锌离子的矿物质、含锰离子的矿物质、含钙离子的矿物质、含碘离子的矿物质、含硒离子的矿物质中的任一种或更多种。
在本申请中，所述氨基酸可以选自L-赖氨酸、L-亮氨酸、L-异亮氨酸、L-精氨酸、左旋肉碱和牛磺酸的任一种或更多种。
在本申请中，所述核苷酸可以选自肌苷酸二钠、鸟苷酸二钠、胞甘酸二钠和尿苷酸二钠中的任一种或更多种。
在本申请中，所述脂肪可以选自植物油、亚油酸、亚麻酸、中链脂肪酸甘油酯和长链脂肪酸甘油酯中的任一种或更多种。
在本申请中，所述膳食纤维可以选自可溶性膳食纤维和不溶性膳食纤维中的一种或两种；
所述可溶性膳食纤维可以选自豆胶、果胶、树胶和低聚果糖中的任一种或更多种；所述不溶性膳食纤维可以选自纤维素、半纤维素和木质素中的任一种或更多种。
在本申请中，所述碳水化合物可以选自藕粉、莲子粉和山药粉或全麦粉中的任一种或更多种。
本申请还提供所述特殊医学用途食品的制备方法，所述制备方法包括：
将蛋白质、维生素、矿物质、碳水化合物、脂肪、膳食纤维和氨基酸混合。
在本申请中，所述制备方法包括：
将蛋白质、维生素、矿物质、碳水化合物、脂肪、膳食纤维和氨基酸在温度18℃-22℃，湿度45％-65％下混合混匀，然后加入特殊医学用途食品可接受的添加剂，获得所述口服制剂。
本申请还提供所述特殊医学用途食品用于降低血糖的用途。
本申请的特殊医学用途食品改善胰岛素抵抗从而能有效降低血糖，减少并发症的产生。
本申请的其它特征和优点将在随后的说明书中阐述，并且，部分地从说明书中变得显而易见，或者通过实施本申请而了解。本申请的目的和其他优点可通过在说明书以及权利要求书中所特别指出的结构来实现和获得。
具体实施方式
为使本申请的目的、技术方案和优点更加清楚明白，下文中将对本申请的实施例进行详细说明。需要说明的是，在不冲突的情况下，本申请中的实施例及实施例中的特征可以相互任意组合。
实施例
一、按配方比例称量所需各种原料，
1)将所述维生素包括维生素A醋酸视黄酯(10％)12mg、【B族维生素(维生素B19mg、维生素B2 9mg、维生素B6 9mg，维生素B12(0.1％)1.5mg】，维生素D3(0.25％)11mg、胆碱2.4g、维生素E 74mg、维生素C 308mg、D-生物素2％7mg、烟酸19mg、肌醇2.4g、D-泛酸钙25mg、叶酸0.72mg，维生素K2(0.2％)0.2g、维生素K1 0.25mg以上各种维生素先采用等量递增的方法手工混合，再过60目不锈钢筛网3次得到混合均匀粉1。
2)将所述矿物质氯化钠7.5g、磷酸二氢钾8.5g、葡萄糖酸铜18.6mg、硫酸镁3g、柠檬酸亚铁1.6g、葡萄糖酸锌350mg、硫酸锰16.8mg、碳酸钙7g、碘化钾0.3mg、富硒酵母0.25g以上矿物质先采用等量递增的方法手工混合，再过60目不锈钢筛网3次得到混合均匀粉2。
3)将所述氨基酸可以是L-赖氨酸0.8g、L-亮氨酸1.3g、L-异亮氨酸0.9g、L-精氨酸0.8g、左旋肉碱1.0g、牛磺酸1g，以上氨基酸采用等量递增的方法手工混合，再过60目不锈钢筛网3次得到混合均匀粉料3。
4)将所述膳食纤维可溶性膳食纤维：豆胶18g，果胶17g，树胶16g，低聚果糖56g；不溶性膳食纤维：纤维素19g，半纤维素20g，木质素12g。先采用等量递增的方法手工混合，再过60目不锈钢筛网3次得到混合均匀粉料。
5)将所述脂肪的植物油6g、亚油酸8g、亚麻酸10g、中链脂肪酸甘油酯10g、长链脂肪酸甘油酯6g中的植物油、亚油酸、亚麻酸先采用与等量4)粉稀释，再加入中链脂肪酸甘油酯、长链脂肪酸甘油酯进行混合，再过60目不锈钢筛网3次得到混合均匀粉料4。
6)所述碳水化合物藕粉38g，莲子粉40g，山药粉50g，全麦粉30g先采用等量递增的方法手工混合，再过60目不锈钢筛网3次得到混合均匀粉料6。
7)将所述核苷酸包括肌苷酸二钠30mg，鸟苷酸二钠20mg，胞甘酸二钠10mg，尿苷酸二钠10mg，先采用等量递增的方法手工混合，再过60目不锈钢筛网3次得到混合均匀粉料7。
8)将所述蛋白质的大豆蛋白粉27g，核桃粉15g，小麦粉14g，乳清蛋白粉12g，先采用等量递增的方法手工混合，再过60目不锈钢筛网3次得到混合均匀粉料8。
以上的操作环境都是在十万级洁净车间完成，温度18-22℃，湿度是45-65％。
二、将以上粉料1-8在依次置于GHL-300B高效湿法混合制粒机中混合均匀，再加入所需的(1-2％按物料重量计)硬脂酸镁或者浓度10％淀粉浆10％-15％(按重量计)制成口服制剂。
三、本申请制剂的降血糖效果。
随机选取50名二型糖尿病患作为志愿者并签署知情同意书，将志愿者随机分成两组，对照组和治疗组，其中对照组共25例，年龄最小30岁，最大60岁，平均(45.5±7.91)岁，男14例，女11例。治疗组共25例，年龄最小28岁，最大58岁，平均(46.63±7.68)岁，男15例，女10例。对照组每日三餐食用按照原方式进行，治疗组每日三餐前给予按照具体实施方式中实施例2的方法制备的粉剂，每次150g，用300ml的37-40℃的温开水冲调服用；两组人员餐前及餐后5min，0.5、1、2、3小时分别测其血糖，连续进行十天，实验期间两组人员中、晚餐种类和食用量相同，降糖药物的种类和使用剂量均保持不变；随后两组均继续治疗，以90天为一个疗程，一个疗程后评定对餐后血糖的影响。
试验结果：对照组和治疗组各个时段血糖(mmol/l)的变化(x±s)
表1治疗前对照组和治疗组的血糖水平
| 组别 | 空腹 | 餐后5min | 餐后0.5h | 餐后1h | 餐后2h | 餐后3h |
| 对照组 | 7.05±0.28 | 9.59±0.62 | 12.10±0.89 | 13.63±0.89 | 12.10±0.89 | 10.35±0.58 |
| 治疗组 | 7.12±0.27 | 9.53±0.38 | 11.30±0.63 | 10.36±0.70 | 10.36±0.59 | 9.65±0.68 |
表2一个疗程后，对照组和治疗组的血糖水平
| 组别 | 空腹 | 餐后5min | 餐后0.5h | 餐后1h | 餐后2h | 餐后3h |
| 对照组 | 7.12±0.32 | 9.28±0.32 | 11.80±0.45 | 13.31±0.74 | 11.60±0.25 | 10.15±0.53 |
| 治疗组 | 6.82±0.61 | 8.50±0.35 | 9.30±0.60 | 8.62±0.63 | 7.82±0.69 | 7.65±0.43 |
从表1和表2可以看出，在治疗前，对照组跟治疗组各个时段的血糖差异并不大，经过一个疗程的代餐饮食后，治疗组各个时段的血糖值都比对照组低，并且没有出现一个过高的峰值。说明本申请的特殊医学用途食品具有降低血糖的作用。
虽然本申请所揭露的实施方式如上，但所述的内容仅为便于理解本申请而采用的实施方式，并非用以限定本申请。任何本申请所属领域内的技术人员，在不脱离本申请所揭露的精神和范围的前提下，可以在实施的形式及细节上进行任何的修改与变化，但本申请的专利保护范围，仍须以所附的权利要求书所界定的范围为准。
Claims (15)
1.一种特殊医学用途食品，其中，所述特殊医学用途食品包含蛋白质13重量％-17重量％，维生素0.5重量％-1.5重量％，矿物质4重量％-7重量％，碳水化合物30重量％-40重量％，脂肪8重量％-10重量％，膳食纤维30重量％-43重量％，氨基酸1重量％-1.5重量％和核苷酸0.01重量％-0.02重量％。
2.根据权利要求1所述的特殊医学用途食品，所述特殊医学用途食品还包含特殊医学用途食品可接受的添加剂；
所述特殊医学用途食品可接受的添加剂选自润滑剂和润湿剂中的一种或两种。
3.根据权利要求1或2所述的特殊医学用途食品，其中，所述特殊医学用途食品为口服制剂，优选地片剂或颗粒剂。
4.根据权利要求3所述的特殊医学用途食品，其中，所述特殊医学用途食品为分散片、含化片或口嚼片。
5.权利要求1所述的特殊医学用途食品，其中，所述蛋白质选自大豆蛋白粉、核桃粉、小麦粉和乳清蛋白中的任一种或更多种；
所述大豆蛋白为分离大豆蛋白粉或浓缩大豆蛋白粉；
所述乳清蛋白为分离乳清蛋白或浓缩乳清蛋白。
6.根据权利要求1、2和5中任一项所述的特殊医学用途食品，其中，所述维生素选自维生素A、B族维生素、D族维生素、氧化胆碱、维生素E、维生素C、D-生物素、烟酸、肌醇、D-泛酸钙、叶酸、维生素K2和维生素K1中的任一种或更多种；
所述维生素A为类胡萝卜素前体物质；
所述B族维生素选自维生素B1、维生素B2、维生素B6、维生素12、维生素B1前体、维生素B2前体、维生素B前体6和维生素12前体中的任一种或更多种；
所述D族维生素选自D2、维生素D3、维生素D2前体和维生素D3前体中的任一种或更多种，优选维生素D3；
所述维生素K2选自化学合成或天然发酵的MK1至MK14中的任一种或更多种，优选天然发酵的MK-7。
7.根据权利要求1、2和5中任一项所述的特殊医学用途食品，其中，所述矿物质选自含钠离子的矿物质、含钾离子的矿物质、含铜离子的矿物质、含镁离子的矿物质、含铁离子的矿物质、含锌离子的矿物质、含锰离子的矿物质、含钙离子的矿物质、含碘离子的矿物质、含硒离子的矿物质中的任一种或更多种。
8.根据权利要求1、2和5中任一项所述的特殊医学用途食品，其中，所述氨基酸选自L-赖氨酸、L-亮氨酸、L-异亮氨酸、L-精氨酸、左旋肉碱和牛磺酸中的任一种或更多种。
9.根据权利要求1、2和5中任一项所述的特殊医学用途食品，其中，所述核苷酸选自肌苷酸二钠、鸟苷酸二钠、胞甘酸二钠和尿苷酸二钠中的任一种或更多种。
10.根据权利要求1、2和5中任一项所述的特殊医学用途食品，其中，所述脂肪选自植物油、亚油酸、亚麻酸、中链脂肪酸甘油酯和长链脂肪酸甘油酯中的任一种或更多种。
11.根据权利要求1、2和5中任一项所述的特殊医学用途食品，其中，所述膳食纤维选自可溶性膳食纤维和不溶性膳食纤维中的一种或两种；
所述可溶性膳食纤维选自豆胶、果胶、树胶和低聚果糖中的任一种或更多种；所述不溶性膳食纤维选自纤维素、半纤维素和木质素中的任一种或更多种。
12.根据权利要求1、2和5中任一项所述的特殊医学用途食品，其中，所述碳水化合物选自藕粉、莲子粉和山药粉或全麦粉中的任一种或更多种。
13.权利要求1至12中任一项所述的特殊医学用途食品的制备方法，所述制备方法包括：
将蛋白质、维生素、矿物质、碳水化合物、脂肪、膳食纤维和氨基酸混合。
14.根据权利要求13所述的制备方法，其中，所述制备方法包括：
将蛋白质、维生素、矿物质、碳水化合物、脂肪、膳食纤维和氨基酸在温度18℃-22℃，湿度45％-65％下混合混匀，然后加入特殊医学用途食品可接受的添加剂，获得所述口服制剂。
15.根据权利要求1至12中任一项所述的特殊医学用途食品用于降低血糖的用途。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910465903.XA CN110122862A (zh) | 2019-05-31 | 2019-05-31 | 一种降低血糖的特殊医学用途食品及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910465903.XA CN110122862A (zh) | 2019-05-31 | 2019-05-31 | 一种降低血糖的特殊医学用途食品及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110122862A true CN110122862A (zh) | 2019-08-16 |
Family
ID=67583150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910465903.XA Pending CN110122862A (zh) | 2019-05-31 | 2019-05-31 | 一种降低血糖的特殊医学用途食品及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110122862A (zh) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050202063A1 (en) * | 2003-08-26 | 2005-09-15 | Ebn International Kft | Food product |
| CN103478527A (zh) * | 2013-08-23 | 2014-01-01 | 内蒙古伊利实业集团股份有限公司 | 一种低血糖生成指数营养粉 |
| CN106690290A (zh) * | 2016-11-25 | 2017-05-24 | 广州市赛健生物科技有限公司 | 一种高膳食纤维全营养特殊医学用途配方食品及其制备方法 |
| CN107072276A (zh) * | 2014-09-01 | 2017-08-18 | 马修·乔利·瓦达科姆里 | 一种优化的营养食品 |
| CN107822116A (zh) * | 2017-11-13 | 2018-03-23 | 福建省水产研究所（福建水产病害防治中心） | 适用于糖尿病患者的海洋短肽型特殊医学用途配方食品 |
| CN108208802A (zh) * | 2017-12-31 | 2018-06-29 | 西安凯伦生物科技有限公司 | 一种适合糖尿病患者食用的特殊膳食及其制备方法 |
| CN108991506A (zh) * | 2018-07-18 | 2018-12-14 | 辰欣药业股份有限公司 | 一种不含纤维的预消化高能医用配方食品及其制备方法 |
-
2019
- 2019-05-31 CN CN201910465903.XA patent/CN110122862A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050202063A1 (en) * | 2003-08-26 | 2005-09-15 | Ebn International Kft | Food product |
| CN103478527A (zh) * | 2013-08-23 | 2014-01-01 | 内蒙古伊利实业集团股份有限公司 | 一种低血糖生成指数营养粉 |
| CN107072276A (zh) * | 2014-09-01 | 2017-08-18 | 马修·乔利·瓦达科姆里 | 一种优化的营养食品 |
| CN106690290A (zh) * | 2016-11-25 | 2017-05-24 | 广州市赛健生物科技有限公司 | 一种高膳食纤维全营养特殊医学用途配方食品及其制备方法 |
| CN107822116A (zh) * | 2017-11-13 | 2018-03-23 | 福建省水产研究所（福建水产病害防治中心） | 适用于糖尿病患者的海洋短肽型特殊医学用途配方食品 |
| CN108208802A (zh) * | 2017-12-31 | 2018-06-29 | 西安凯伦生物科技有限公司 | 一种适合糖尿病患者食用的特殊膳食及其制备方法 |
| CN108991506A (zh) * | 2018-07-18 | 2018-12-14 | 辰欣药业股份有限公司 | 一种不含纤维的预消化高能医用配方食品及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104286849A (zh) | 一种糖尿病专用型肠内营养多聚合剂 | |
| CN106473153A (zh) | 全营养配方食品及其制备方法 | |
| CN105613789A (zh) | 一种高脂高膳食纤维复合动植物粉末油脂、其制备方法及应用 | |
| CN108077911A (zh) | 一种癫痫患者专用型临床营养配方及其制备方法 | |
| CN103431392B (zh) | 一种供糖尿病患者食用的复合海洋特膳食品 | |
| US9308222B2 (en) | Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis | |
| JP2008247748A (ja) | 透析患者用栄養組成物 | |
| WO2014204382A1 (en) | Administration of a food composition product | |
| KR20070113460A (ko) | 체중조절용 건강식품 조성물 | |
| CN100515430C (zh) | 补充钙镁和维生素d的药品制剂 | |
| KR20200016608A (ko) | 체중조절용 건강식품 조성물 | |
| CN110584120A (zh) | 骨健康组合物 | |
| CN105581331A (zh) | 一种补钙营养组合物 | |
| CN109090319A (zh) | 乳矿物盐压片糖果 | |
| CN110122862A (zh) | 一种降低血糖的特殊医学用途食品及其制备方法 | |
| AU2012288401B2 (en) | Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis | |
| Abd El Majid et al. | Effect of Calcium, Vitamin D and Chia Seeds on Rats Suffering from Osteoporosis | |
| CN107595829B (zh) | 一种防治肾性骨营养不良的组合物 | |
| CN1736221B (zh) | 一种降低或保持体重的奶粉及其制备方法 | |
| CN110122863A (zh) | 一种改善肝功能的特殊医学用途食品及其制备方法 | |
| KR20170136929A (ko) | 산양산삼을 이용한 이유식 및 그 제조방법 | |
| CN103796658A (zh) | 含有高溶性元素和维生素并能预防和改善骨质疏松症的组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |